documents: FDA-2014-D-0622-0006

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2014-D-0622-0006 FDA FDA-2014-D-0622 Draft Guidance for Industry on Best Practices in Developing Proprietary Names for Drugs; Reopening of the Comment Period Notice Extension of Comment Period 2014-08-14T04:00:00Z 2014 8 2014-08-14T04:00:00Z 2014-09-16T03:59:59Z 2014-10-16T01:02:12Z 2014-19261 0 0 090000648182216b

Links from other tables